Consequently, combination therapy with anti‐PD‐L1 antibodies demonstrated notable synergistic effects, effectively inhibiting the growth of primary and metastatic tumors and inducing long‐term immune memory. This evidence concerns the gene CD274 and metastatic neoplasm.